• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FINELINE II EZ STEROX; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FINELINE II EZ STEROX; IMPLANTABLE LEAD Back to Search Results
Model Number 4473
Medical Device Problem Codes Failure to Capture (1081); High Capture Threshold (3266)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/21/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that this right atrial (ra) lead was explanted due to high pacing thresholds.A new lead with different model was implanted.No additional adverse patient effects were reported.
 
Event or Problem Description
It was reported that this right atrial (ra) lead was explanted due to high pacing thresholds.A new lead with different model was implanted.No additional adverse patient effects were reported.Additional information indicated that this ra lead had no capture.
 
Additional Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the lead was performed.Testing was completed to assess lead electrical performance and passed.Microscopic inspections of the outer insulation found to be missing approximately 315 to 435 millimeters from the terminal end, and there were three bends in the lead body approximately 150, 210 and 335 millimeters from the terminal end.Laboratory testing was unable to reproduce the reported clinical observations, and detailed analysis did not reveal any abnormalities.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported clinical observations.
 
Event or Problem Description
It was reported that this right atrial (ra) lead was explanted due to high pacing thresholds.A new lead with different model was implanted.No additional adverse patient effects were reported.Additional information indicated that this ra lead had no capture.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FINELINE II EZ STEROX
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key22813710
Report Number2124215-2025-57070
Device Sequence Number5739041
Product Code DTB
UDI-Device Identifier00802526265020
UDI-Public(01)00802526265020(17)141121
Combination Product (Y/N)Y
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P960004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2013
Device Explanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date11/21/2014
Device Model Number4473
Device Catalogue Number4473
Device Lot Number484583
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/28/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/21/2025
Supplement Date Received by Manufacturer09/03/2025
10/28/2025
Initial Report FDA Received Date08/15/2025
Supplement Report FDA Received Date09/08/2025
11/24/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/21/2012
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age87 YR
Patient SexMale
-
-